Are haemoglobin levels adequate in patients with chronic kidney disease (ckd) stage 2–4?

Conclusion and Application to PracticeMore emphasis should be placed on detection and treatment of anaemia in earlier stages of kidney disease. Poor response to erythropoiesis stimulating agent therapy should be investigated in this group and any identified causes of poor response treated.

Source: Journal of Renal Care - June 1, 2013 Category: Urology & Nephrology Authors: Lynette Trowbridge, Ann Kruger, Anne Arnold, Belinda Butcher, Jennifer Bradley Tags: Audit Source Type: research